These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

207 related items for PubMed ID: 3521617

  • 1. Effect of curcumin on platelet aggregation and vascular prostacyclin synthesis.
    Srivastava R, Puri V, Srimal RC, Dhawan BN.
    Arzneimittelforschung; 1986 Apr; 36(4):715-7. PubMed ID: 3521617
    [Abstract] [Full Text] [Related]

  • 2. Inhibition of arterial PGI2 generation and platelet aggregation by aspirin in rabbits ex vivo.
    Basista M.
    Pol J Pharmacol Pharm; 1982 Apr; 34(5-6):317-21. PubMed ID: 6821216
    [Abstract] [Full Text] [Related]

  • 3. Control of human and animal platelet aggregation by a new prostacyclin analog.
    Maderna P, Colli S, Sirtori C, Tremoli E, Paoletti R.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Apr; 13():363-9. PubMed ID: 2408447
    [Abstract] [Full Text] [Related]

  • 4. Meseclazone, 5-chlorosalicylic acid and acetylsalicylic acid. Comparison of their effects on in vitro and ex vivo platelet aggregation.
    Diamantis W, Kohlhepp WC, Haertlein B, Melton J, Sofia RD.
    Thromb Haemost; 1978 Aug 31; 40(1):24-36. PubMed ID: 103240
    [Abstract] [Full Text] [Related]

  • 5. [Effect of flurbiprofen on platelet functions. Study of its interference with the synthesis of platelet thromboxane and production of prostacyclin by the rabbit aorta].
    Levy-Toledano S, Maclouf J, Caen J, Bara L, Lecrubier C, Samama M.
    J Pharmacol; 1983 Aug 31; 14(2):141-50. PubMed ID: 6408316
    [Abstract] [Full Text] [Related]

  • 6. [Effect of acetylsalicylic acid on platelet aggregation and capillary bleeding in healthy cats].
    Hart S, Deniz A, Sommer B, Kietzmann M, Nolte I.
    Dtsch Tierarztl Wochenschr; 1995 Dec 31; 102(12):476-80. PubMed ID: 8591748
    [Abstract] [Full Text] [Related]

  • 7. Levamisole inhibits in vivo rat platelet aggregation by a release of prostacyclin-like factor.
    Pinto A, Sorrentino R, Sorrentino L.
    Gen Pharmacol; 1990 Dec 31; 21(2):255-9. PubMed ID: 2110089
    [Abstract] [Full Text] [Related]

  • 8. Pharmacological properties of the novel anti-platelet aggregating agent 4-cyano-5,5-bis(4-methoxyphenyl)-4-pentenoic acid.
    Fujimori T, Harada K, Saeki T, Kogushi M, Akasaka K, Yamagishi Y, Yamatsu I.
    Arzneimittelforschung; 1987 Oct 31; 37(10):1143-8. PubMed ID: 3124862
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The influence of oral hypoglycaemic sulfonyl ureas on prostacyclin release by the rat thoracic aorta.
    el Tahir KE, Ali AE, Abu Nasif MA, Ageel AM, Gadkarim EA.
    Arch Int Pharmacodyn Ther; 1986 Sep 31; 283(1):134-40. PubMed ID: 3099669
    [Abstract] [Full Text] [Related]

  • 11. Platelet antiaggregant activity of plafibride ex vivo in rat, dog and rabbit.
    Bruseghini L, Vilageliu J, Freixes J.
    Arzneimittelforschung; 1981 Sep 31; 31(10a):1790-5. PubMed ID: 6797443
    [Abstract] [Full Text] [Related]

  • 12. Exposure to carbon monoxide or to nicotine does not inhibit PGI2 formation by rat arterial rings incubated with human platelet-rich plasma.
    Hartiala J, Simberg N, Uotila P.
    Artery; 1982 Sep 31; 10(6):412-9. PubMed ID: 6760833
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Octahydroindolo[2,3-a]quinolizines and 3,4-dihydro-beta-carbolines as new inhibitors of human platelet aggregation.
    Blaskó G, Blaskó G, Szántay C.
    Arzneimittelforschung; 1987 Jun 31; 37(6):667-9. PubMed ID: 3311053
    [Abstract] [Full Text] [Related]

  • 15. [Modifications of platelet function induced by ASA. I. Effects on aggregation].
    Piro F, Capetti P.
    Boll Soc Ital Biol Sper; 1979 Sep 30; 55(18):1895-901. PubMed ID: 553563
    [Abstract] [Full Text] [Related]

  • 16. Verapamil and the synthesis of prostacyclin in human veins.
    Fahr A, Langer R, Sziegoleit W, Blauschmidt J, Albert H, Liebal H, Mest HJ.
    Pharmazie; 1991 Mar 30; 46(3):213-4. PubMed ID: 1881946
    [Abstract] [Full Text] [Related]

  • 17. The action of flupirtine on prostaglandin formation and platelet aggregation in vitro.
    Darius H, Schrör K.
    Arzneimittelforschung; 1985 Mar 30; 35(1):55-9. PubMed ID: 3885962
    [Abstract] [Full Text] [Related]

  • 18. Influence on platelet activity and red cell fluidity of epoprostenol and two stable prostacyclin analogues in vitro.
    Maurin N.
    Arzneimittelforschung; 1986 Aug 30; 36(8):1180-3. PubMed ID: 3096342
    [Abstract] [Full Text] [Related]

  • 19. Generation of a PGI2-like activity by deendothelialized rat aorta.
    Ts'ao CH, Holly CM, Serieno MA, Galluzzo TS.
    Thromb Haemost; 1979 Oct 31; 42(3):873-84. PubMed ID: 388719
    [Abstract] [Full Text] [Related]

  • 20. Effect of platelet antigen polymorphism on platelet inhibition by aspirin, clopidogrel, or their combination.
    Cooke GE, Liu-Stratton Y, Ferketich AK, Moeschberger ML, Frid DJ, Magorien RD, Bray PF, Binkley PF, Goldschmidt-Clermont PJ.
    J Am Coll Cardiol; 2006 Feb 07; 47(3):541-6. PubMed ID: 16458133
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.